Title
Parents’ perceptions and intention to vaccinate their children under 12 years of age against COVID-19: a cross-sectional study in Peru
Other title
Percepciones e intención de los padres de vacunar a sus hijos bajo 12 años de edad contra la COVID-19: estudio transversal en Perú.
Date Issued
01 June 2022
Access level
open access
Resource Type
journal article
Author(s)
Gonzales-Zamora J.A.
Soriano A.N.
Ponce-Rosas L.
De-Los-rios-pinto A.
Murrieta-Ruiz V.T.
Morocho-Alburqueque N.
Caira-Chuquineyra B.
Publisher(s)
Sociedad Chilena de Infectologia
Abstract
Background: Despite the proven efficacy and safety of COVID-19 vaccines, pediatric vaccination coverage remains low in many coun-tries. There are still doubts and fears in parents about vaccination in their children under 12 years of age. Aim: To evaluate the perceptions and intention of parents to vaccinate their children under 12 years of age. Methods: Analytical cross-sectional study based on an online survey that evaluated the parents’ perceptions regarding the risk of COVID-19 infection, the need for a vaccine, and the vaccine adverse events in their children under 12 years. We assessed the factors associated with the intention to vaccinate through crude (cPR) and adjusted prevalence rates (aPR), with confidence interval of 95% (CI 95%). Results: 83.5% of respondents had the intention to vaccinate their children under 12 years of age. In the multivariate analysis, the factors associated with a decrease in the intention to vaccinate were to believe that the vaccine was not necessary (aPR 0.65; 95% CI 0.44-0.94), that it would not protect (aPR: 0.14; 95% CI 0.03-0.63), it would not be safe (aPR: 0.80; 95% CI 0.70-0.92) and it would cause long-term side effects (aPR: 0.92; 95% CI 0.85-1.00). On the other hand, living on the highlands or jungle was associated with an increase in the intention. Conclusions: In Peru, 16.5% of parents would not vaccinate their children under 12 years of age, because they perceived that the vaccine was not necessary and would not protect against COVID-19. In addition, they expressed concerns about the development of possible adverse events.
Start page
273
End page
286
Volume
39
Issue
3
Language
Spanish
OCDE Knowledge area
Enfermedades infecciosas
Sistema respiratorio
Farmacología, Farmacia
Subjects
Scopus EID
2-s2.0-85138156959
PubMed ID
Source
Revista Chilena de Infectologia
ISSN of the container
07161018
Sources of information:
Directorio de Producción Científica
Scopus